Hemothorax Caused by Primary Pulmonary Angiosarcoma
Journal Title: Pulmonary Research and Respiratory Medicine – Open Journal - Year 2015, Vol 2, Issue 1
Abstract
A previously healthy 57-year-old woman was admitted to the Emergency Department with hemothorax. She had continuously blood loss during the next 24 hours accordingly she went to the OR in order to achieve hemostasis. Intraoperative findings were multiple lesions in the lung parenchyma and diffuse bleeding from multiple small abnormal nodules on the surface of the visceral pleural and parietal pleura. Biopsies prompted the diagnosis of angiosarcoma and with the primary tumour burden in the lung parenchyma the pathologist diagnosed a primary pulmonary angiosarcoma. The disease was widespread at the time of diagnosis accordingly curative intended treatment was not an option and because of her general poor condition, she died one day after discharge.
Authors and Affiliations
Katrine Lawaetz Kristensen
Keywords
Related Articles
- EP ID EP550044
- DOI 10.17140/PRRMOJ-2-106
- Views 171
- Downloads 0
Recent Advances in Pulmonary Rehabilitation for Patients with COPD
Pulmonary rehabilitation (PR) is a non-pharmacologic therapy that has emerged as a standard of care for patients with chronic obstructive pulmonary disease (COPD). It is a comprehensive, multidisciplinary, patient-center...
Pulmonary Rehabilitation in Patients With Pulmonary Hypertension
Traditionally, patients with pulmonary hypertension (PH) were advised to limit their physical activity because of the risk of fatal cardiovascular compromise. However, relatively little is known about the risks and benef...
Hemothorax Caused by Primary Pulmonary Angiosarcoma
A previously healthy 57-year-old woman was admitted to the Emergency Department with hemothorax. She had continuously blood loss during the next 24 hours accordingly she went to the OR in order to achieve hemostasis. Int...
Editorial Summary to the Special Edition on “Recent Advances in Pulmonary Rehabilitation”
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, and contributes substantially to annual healthcare expenditure. Key management strategies for people with COPD target symptom re...
Comparison of Next-Generation Sequencing Platforms for Clinical Testing of Non-Small Cell Lung Cancer
Personalized treatment of lung cancer using therapies that target activating oncogenic mutations such as EGFR and ALK has become the standard of care. Current molecular testing is routinely performed for single genes and...